Canaan IX L.P., Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 8,687 shares at $10.14 ($88K) on 2016-05-19, disclosed to the SEC on 2016-05-23.
Open-market sale of $88k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.14 | 2,500 | $25K | 28.9% |
| 2 | $10.09 | 6,187 | $62K | 71.1% |
| Total | $10.10 avg | 8,687 | $88K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-14 | $1.9M | — | Filing → |